INHIBITORY EFFECT OF A TRADITIONAL CHINESE MEDICINE, JUZEN-TAIHO-TO, ON PROGRESSIVE GROWTH OF WEAKLY MALIGNANT CLONE CELLS DERIVED FROM MURINE FIBROSARCOMA
Y. Ohnishi et al., INHIBITORY EFFECT OF A TRADITIONAL CHINESE MEDICINE, JUZEN-TAIHO-TO, ON PROGRESSIVE GROWTH OF WEAKLY MALIGNANT CLONE CELLS DERIVED FROM MURINE FIBROSARCOMA, Japanese journal of cancer research, 87(10), 1996, pp. 1039-1044
We have investigated the inhibitory effect of oral administration of J
uzen-taiho-to, a Kampo (Chinese herbal) medicine, on progressive growt
h of a mouse fibrosarcoma. spontaneously regressive QR-32 tumor cells
were able to grow progressively in vivo when coimplanted s.c. with a f
oreign body, gelatin sponge, whereas QR-32 cells alone gradually grew
for over 15 days after inoculation and thereafter regressed for up to
25 days. Oral administration of Juzen-taiho-to (40 mg/day/mouse) for 7
days after inoculation of QR-32 cells with gelatin sponge resulted in
significant inhibition of tumor growth and prolongation of the surviv
al of the tumor-bearing mice, This growth-inhibitory effect of Juzen-t
aiho-to observed on day 25 was dose-dependent over the dose range from
4 to 40 mg/day. Treatment with Juzen-taiho-to for 7 days before tumor
inoculation with gelatin sponge also significantly suppressed tumor g
rowth examined on day 25, as did the administration of bismuth subnitr
ate, which is well known to induce metallothionein, an antioxidant. On
the other hand, inoculation of progressed tumor cells (QRsP) resulted
in growth without gelatin sponge, leading to death in syngeneic mice,
Administration of Juzen-taiho-to for 7 days after inoculation of QRsP
cells resulted in a decrease of the tumor growth and prolongation of
the survival of mice, but the effect was less than that on the growth
of QR-32 regressor tumor after coimplantation with gelatin sponge. The
se results suggest that the inhibitory effect of Juzen-taiho-to is par
tly associated with prevention of gelatin sponge-elicited progressive
growth, probably mediated by endogenous factors including antioxidant
substances, in addition to the augmentation of host-mediated antitumor
activity.